Chemotherapeutic Activity of 5-Fluorocytosine and Amphotericin B Against Candida albicans in Mice
AUTOR(ES)
Titsworth, E.
RESUMO
The effect of treatment with combinations of the two antifungal agents, 5-fluorocytosine (5-FC) and amphotericin B (AB), against systemic Candida albicans infections in mice was investigated. Graded doses of the single substances and of combinations of the drugs were administered daily for 21 days. The 50% curative dose (CD50) values were calculated on the basis of the presence or absence of C. albicans in cultures prepared from the kidneys of animals that succumbed during the experimental period or were sacrificed at the termination of the experiments. Overall, when graded doses of AB were administered in the presence of a constant, inactive dose of 5-FC (approximately one-half to one-fourth the CD50 of 5-FC), the CD50 values for AB were lower than those for amphotericin B alone. Similarly, the CD50s for 5-FC were reduced when AB was administered at a constant dose equal to one-half to one-fourth the CD50 of AB alone. In no instance was there evidence of antagonism.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=444547Documentos Relacionados
- Chemotherapeutic Activity of 5-Fluorocytosine Against a Lethal Candida albicans Infection in Mice
- Efficacies of High-Dose Fluconazole plus Amphotericin B and High-Dose Fluconazole plus 5-Fluorocytosine versus Amphotericin B, Fluconazole, and 5-Fluorocytosine Monotherapies in Treatment of Experimental Endocarditis, Endophthalmitis, and Pyelonephritis Due to Candida albicans
- In Vitro Activity of 5-Fluorocytosine Against Candida and Torulopsis Species
- 5-Fluorocytosine and Amphotericin B in Bronchial Secretions
- Complementation analysis of resistance to 5-fluorocytosine in Candida albicans.
